Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-110972
Filing Date
2025-11-14
Accepted
2025-11-14 16:47:11
Documents
70
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0265115-10q_abpro.htm   iXBRL 10-Q 1389671
2 CERTIFICATION ea026511501ex31-1_abpro.htm EX-31.1 10213
3 CERTIFICATION ea026511501ex32-1_abpro.htm EX-32.1 4085
  Complete submission text file 0001213900-25-110972.txt   7472389

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE abp-20250930.xsd EX-101.SCH 76411
5 XBRL CALCULATION FILE abp-20250930_cal.xml EX-101.CAL 33735
6 XBRL DEFINITION FILE abp-20250930_def.xml EX-101.DEF 404036
7 XBRL LABEL FILE abp-20250930_lab.xml EX-101.LAB 672265
8 XBRL PRESENTATION FILE abp-20250930_pre.xml EX-101.PRE 406861
72 EXTRACTED XBRL INSTANCE DOCUMENT ea0265115-10q_abpro_htm.xml XML 765905
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Abpro Holdings, Inc. (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41224 | Film No.: 251487650
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)